Optimization of treatment options for EGFR-mutant, stage III, unresectable NSCLC: A systematic review and meta-analysis

Category Systematic review
JournalJournal of Clinical Oncology
Year 2022
This article has no abstract
Epistemonikos ID: ad3c484a1d7695a250e428f8afbb3460e8eb6004
First added on: Feb 14, 2025